COL11A1 and colorectal carcinoma: Also, an overexpression of COL11A1 has been associated with an adverse outcome in a variety of primaries including breast (MC) [10], colorectum (CRC) [9], ovary (OC) [9, 11], lung [12], bladder [13], kidney [14] and pancreas (PDAC) [15].